Skip to Main content Skip to Navigation
Journal articles

High Affinity Forskolin Inhibition of L-Type Ca2+ Current in Cardiac Cells

Abstract : The diterpene forskolin is widely known for its ability to directly activate adenylyl cyclase and consequently increase intracellular cAMP. In cardiac cells, one result is a cAMP-mediated increase in the L-type Ca2+-channel current (ICa). However, forskolin was also shown recently to affect a number of ionic channels in noncardiac cells by mechanisms that do not involve activation of adenylyl cyclase. The present study reveals such an effect of forskolin on cardiac Ca2+ channels. Indeed, under appropriate conditions, forskolin was found to cause an inhibition of lCa Although the stimulation of adenylyl cyclase and ICa requires micromolar concentrations of forskolin, the inhibitory effect of forskolin was observed in the nanomolar range of concentrations, i.e., 2-3 orders of magnitude lower. This high affinity forskolin inhibition of ICa was observed when lCa was previously enhanced via a cAMP-dependent pathway, but not when ICa was at its basal level or when the current was elevated by the dihydropyridine Bay K 8644. The inhibitory effect occurred at a site of action remote from adenylyl cyclase, because forskolin similarly inhibited lCa that had been previously elevated by isoprenaline (a betaadrenergic agonist) or directly by intracellular perfusion with cAMP. Under these conditions, forskolin was inhibitory when applied to either side of the cell membrane, but only in its lipid soluble form. The inhibitory effect of forskolin appeared to be independent of membrane potential and was not accompanied by a change in the time constants of Iı activation and inactivation. This may indicate that forskolin mainly reduces the number of functional Ca2+ channels without changing the gating of individual channels. However, the reduction in ICa amplitude was not equally distributed among the different exponential components that constitute ICa, which suggests that forskolin also modifies the resting state of the channels. This novel high affinity forskolin inhibition of ICa may take place at some step in the pathway between cAMP and Ca2+ channel phosphorylation and/or at Ca2+ channels only after they have been phosphorylated.
Complete list of metadata
Contributor : RODOLPHE FISCHMEISTER Connect in order to contact the contributor
Submitted on : Thursday, March 24, 2022 - 3:57:07 PM
Last modification on : Tuesday, March 29, 2022 - 11:24:45 AM
Long-term archiving on: : Saturday, June 25, 2022 - 7:34:33 PM


Files produced by the author(s)


  • HAL Id : hal-03618842, version 1
  • PUBMED : 1701212


Mohamed Boutjdir, Pierre-Franqois Méry, Remy Hanf, Alvin Shrier, Rodolphe Fischmeister. High Affinity Forskolin Inhibition of L-Type Ca2+ Current in Cardiac Cells. Molecular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, 1990, 38 (6), pp.758-65. ⟨hal-03618842⟩



Record views


Files downloads